Fight-202: A Phase 2 Study of Pemigatinib in Patients (PTS) with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma (CCA)-MedSci.cn

Fight-202: A Phase 2 Study of Pemigatinib in Patients (PTS) with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma (CCA)

Vogel, A; Sahai, V; Hollebecque, A; Vaccaro, G; Melisi, D; Al-Rajabi, R; Paulson, AS; Borad, MJ; Gallinson, D; Murphy, AG; Oh, DY; Dotan, E; Catenacci, D; Van Cutsem, E; Lihou, C; Zhen, HL; Feliz, L; Abou-Alfa, G

ONCOLOGY RESEARCH AND TREATMENT, 2020; 43 (): 220

科室
- - 订阅+
  - 更多科室
工具
服务